利用寡聚乙二醇( mOEG)修饰海藻酸钠( ALG),有效降低了ALG的黏度,提高了其对疏水性肝靶向配体甘草次酸( GA)的负载量.结果表明,靶向材料( GA-ALG-mOEG)的 GA负载量为11.8%,是对照组( GA-ALG)的1.97倍.在此基础上,以物理交联的方式引入pH响应的阿霉素前药( DOX-ALG-mOEG),制备了肝靶向纳米前药( DOX-ALG-mOEG/GA-ALG-mOEG NPs).细胞实验及抑瘤实验结果表明,该前药较对照组( DOX-ALG/GA-ALG NPs)具有更高的肝靶向性和药物利用率,其对肝癌细胞的半致死率浓度( IC50)为58.1 ng/mL,是对照组( IC50=141.7 ng/mL)的41%;动物实验结果显示,该前药的抑瘤率达到了88.4%,比对照组提高了11.5%.
The high viscosity of sodium alginate( ALG) causes its insufficient targeted ligand loading, and further influences the targeted recognition effect of nano-prodrug. Here, oligomeric ethylene glycol modified-sodium alginate( ALG-mOEG) was used as a carrier to improve the targeted-ligands loading. Results showed that ALG-mOEG significantly improved glycyrrhetinic acid ( GA ) loading compared with unmodified ALG (11.8% vs. 6.9%, 1.97-fold increase) . On this basis, the liver targeted nano-prodrug( DOX-ALG-mOEG/GA-ALG-mOEG NPs ) was self-assembled via dialysis method by mixing GA-ALG-mOEG and DOX-ALG-mOEG. Cell cytotoxicity experiment showed that DOX-ALG-mOEG/GA-ALG-mOEG NPs inhibited HepG2 proliferation with an half maximal inhibitory concentration( IC50 ) value of 58.1 ng/mL while the IC50 of control group was 141.7 ng/mL;the tumor growth inhibition rate( IR) reached to 88.4%, improved by 11.5% com-pared to that of the control group. This study show that the liver targeted nano-prodrug based on ALG-mOEG can effectively improve the drug utilization, and provide a reference for the preparation of other polysaccharide targeted nano-prodrug.